UNSPSC 51281906: Puromycin

This classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula C22H29N7O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4A6ZS6Q2CL, chemically known as 3123l, dihydrochloride but generally known as puromycin, which bears US NIH Compound Identifier 4984. European Medicines Agency schedules Puromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10161MIG. The term PUROMYCIN is an International Non-Proprietary Name.

I cannot write a meaningful summary for UNSPSC 51281906 Puromycin (Commodity tier) based on the source provided. The source contains only the code number and product name; it includes no information about recent state and local procurement activity, issuing bodies, solicitation types, response dates, geographic distribution, or contract opportunities.

To produce a decision-relevant summary, I need the <most-recent-state-local-contract-opportunities> block populated with actual solicitations — the jurisdiction, the notice type, the scope of work, and the response date. Without that data, I cannot characterize what state and local governments are actually buying under this code, which buyers are active, or where opportunities are concentrated.

If you have access to recent RFP, RFQ, IFB, or ITB notices tagged with this code from state agencies, counties, municipalities, school districts, or transit authorities, please provide them and I will generate the summary.